The potential mechanism of HIF-1α and CD147 in the development of triple-negative breast cancer

Menghe Chen,Zitao Liu,Kai Zheng,Chaohua Hu,Pai Peng
DOI: https://doi.org/10.1097/md.0000000000038434
IF: 1.6
2024-06-09
Medicine
Abstract:According to the GLOBOCAN database developed by the International Agency for Research on Cancer, the number of cases of breast cancer has surpassed that of lung cancer to become the cancer type with the highest number of cases and the incidence rate of breast cancer also ranks first in this list. [ 1 ] At present, the molecular typing including Luminal A type, Luminal B type, human epidermal growth factor receptor 2 over-expression and triple-negative breast cancer (TNBC) was closely related to the prognosis of BC. [ 2 , 3 ] As previously reported, TNBC is one of the highly aggressive types and accounts for 15% to 20% of BC with a poor prognosis. [ 4 , 5 ] Chemotherapy is now the main treatment for TNBC patients, but a higher risk of chemotherapy resistance and more serious side effects were observed in the treatment. [ 6 ] Therefore, it is urgent to explore the mechanism of the development of TNBC and find potential therapeutic targets.
medicine, general & internal
What problem does this paper attempt to address?